Both in Pharmaceuticals
Nuvectis Pharma vs DiaMedica Therapeutics
Over the past year NVCT returned +214.1% and DMAC returned +60.5%; their daily moves had a correlation of 0.25.
NVCT +214.1% DMAC +60.5%Growth of $1, one year, split-adjusted
| Metric | NVCT | DMAC |
|---|---|---|
| Price | $18.47 | $10.77 |
| Market cap | $602.9M | $580.8M |
| Today | −4.50% | +7.70% |
| 1 month | −7.8% | +32.5% |
| 6 months | +84.7% | +65.2% |
| Year to date | +144.6% | +35.3% |
| 1 year | +190.4% | +58.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $22.2M | $43.5M |
| Dividend yield | — | — |
| Volatility (60d) | 68.4% | 56.2% |
| Short % of float | 11.7% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).